Ego Pharmaceuticals improved assay efficiency, reduced solvent use, and enhanced UV/Vis precision through automated ...

In a phase 3 trial, the agent reduces seizure frequency by up to 53% in treatment-resistant focal epilepsy, with rapid onset ...

Swiss scientists have published research showing AI-informed robots can learn how to self correct and teach other robots how to behave. It raises questions of consciousness in artificial intelligence.

Thyroid hormones directly regulate cardiovascular function and the imbalance can trigger or severely worsen existing heart ...

Separately, MCC has secured a second option agreement to acquire a 100% interest in licence 393512 (Ouneine Mine) for an ...

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in monthl ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

And we respect that! But maybe you’re of a mind to support our work directly instead? We have until December 31 to raise the ...

The “Science of Engagement” proves that the future of brand loyalty is based on the combination of physics and psychology. As ...

From once-a-week insulin to once-a-month weight loss injections, a new era of convenience is reshaping how doctors treat ...

Outpatient early methadone dose titration – as recommended in Canadian and US clinical guidance for individuals using fentanyl – is associated with improved treatment retention and lower risk of ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), announced today that ...